Hepatitis C and B virus infection in Chinese patients with extrahepatic bile duct carcinoma

Chinese-German Journal of Clinical Oncology

Volumn 1, Issue 1, 2002, Pages 21-27

  Chen, Mingyi ^a   Huang, Zhiqiang ^a   Chen, Lezhen ^a   Gao, Yabing ^b   Peng, Ruiyun ^b   Wang, Dewen ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Etiology; Extrahepatic bile duct carcinoma; Hepatitis B virus; Hepatitis C virus; Immunohistochemistry; In situ polymerase chain reaction

Indexed keywords

EID: 83055170446     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/BF02851789     Document Type: Article

References (45)

1. Anthony PP. In:MaeSween RNM,Anthony PP,Seheuer PJ,eds. Pathology of the Liver: turuours and tumour-like lesions of the liver and biliary tract. 2nd ed. Edinburgh: Churchill Livingstone, 1987. 574.
2. The Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer, 1984,54 : 1747-1755.
3. Moto R, Kawarada Y. In: Okuda K, Ishak KG, eds. N~plasms of the liver: diagnosis and treatment of cholangiocarcinoma and cystic adenocarcinoma of the liver. Tokyo: Spring-Verlag, 1987.381-393.
4. Chearanai O, Plengvanit U, Damrong~ D, et al. Primary liver cancer: angiographic study of 127 cases. J Meal Assoc Thailand, 1984, 67: 482-491.
5. Schwartz DA. Cholangiocarcinoma associated with liver fluke infection: a preventable source of morbidity in Asian immigrants. Am J Gastroenterol, 1986,81 : 76-79.
6. Kurathong S, Lerdverasirikul P,Wonkpaitoon V, et al. Opithorchis viverrini infection and cholangiocarcinoma: a prospective, case-controlled study. Gastroenterology, 1985,89:151-156.
7. Colombari R, Tsui WM. Biliary tumors of the liver. Semin Liver Dis, 1995,15: 402-413.
8. Altaee MY, Johnson PJ, Fan'ant JM, et al. Etiologic and clinical characteristics of peripheral mad hilar cholangiocarcinoma. Cancer, 1991, 68:2051-2055.
9. Huang ZQ, Gu ZY, Zhang XW, et al. Present status of surgical treatment of intrahepatie lithiasis in China: Nation-wide survey of 4197 operative eases 1981-1985. Chin J Surg, 1988,26:513-522.
10. Wang YS, Yang JZ. The diagnosis and treatment of 45 case patients with hepalocholangiocarcinoma accompanying hepatocholelithiasis. Chin J Prac Surg, 1997,17:544-545.
11. l Wang BS, Meng CW. Choice of operation in congenital dilatation of the bile duet in adults. Chin J Surg, 1988,26:287-289.
12. Liang LJ, Hung JF, Lii MD, et al. Cancerization of eholedochal cyst in adults: report of 12 cases. Chin J Prac Surg, 1995,15 : 598-599.
13. Gu HG, Cai JX.Ten cases report on congenital choledochal cyst associated biliary cancer. J Hepatobiliary Surg, 1996,4:49-51.
14. Zhu SH, Zhong XC, Luo ZY. The relationship between Clonorehiasis (Clonorchis sinensis) and other hepatobiliary diseases-clinical aaalysis of 2214 cases. Chin J Intern Med, 1982,21:34-36.
15. Cao XH, Deng BS, Wan DS. Carcinoma of extrahepatic bile duct. Chin J Surg, 1982,22:164-165.
16. Lin SC. Carcinoma of bile duct: A report of 50 cases. Chin J Dig, 1982, 1 : 14-16.
17. Li J, Liu XT, Wang KL, et al. The relationship between clonorehis sinensis infestation and hepatobiliary tumor. Chin Prin~ry Health Care, 1998,12 (4) :39.
18. Zhou NX, Huang ZQ, Liu YX, et al. Analysis of 1098 cases of careinoma of extrahepatic bile duct in China. Chin J Surg, 1990,28:516-519.
19. Shi JS, Zhou IS, Wang ZR, et al. Retrospeetive analysis of 830 extrahepatic biliary carcinoma. Chin J Surg, 1997,35:645-648.
20. Huang ZQ. Fifty-year biliary surgery in China. Chin J Surg, 1999,37:522-525.
21. Tao QM, Wang Y, Wang H. Investigation of anti-HCV in 391 serum samples in China. Chin Meal J, 1990,103:616-618.
22. Kang SX, Ma XK, Zhang XT, el at. Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China. Chin J Epidemiol, 1993,14 : 271-274.
23. Xu ZY, Xu DZ. In: Luo KX, ed. Hepatitis B-basic biology and clinical science: the prevalence. Belling: People' s Medical Publishing House, 1997. 158-159
24. Colono M. Natural history and pathogenesis of hepatitis C virus related hepatocellular caminoma. J Hepatol, 1999,31 (suppl. 1 ) : 25-30.
25. Feitelson MA. Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol, 1999,181 : 188-202.
26. Blum HE, Stowering L, Figus A, et al. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular dements by in situ hybridization. Proc Natl Acad Sci USA, 1983,80:6685-6688.
27. Nouri Aria KT, Sallie R, Sangar D, et al. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin invest, 1993,91 : 2226-2234.
28. Walker FM, Dazza MC, Dauge MC, et al. Detection and localization by in situ molecular biology techniques and immunohistochemistry of hepatitis C virus in livers of chronically infected patients. J Histochem Cytochem, 1998,46: 6536-6560.
29. Wu XZ, Zhang H, Ye QH, et al. HBV DNA detection and immunohistochemistry assay in the embedded-paraffin tissues of primary intrahepatocholangiocarcinoma. Chin J Surg, 1998,36:720.
30. Wang CJ, Wang WL, Wang BY. The distrihution and significance of hepatitis C virus C33c antigen, core antigen and HBxAg in human primary intr~ epatocholangiocarcinoma tissues. J Fourth Milit Meal Univ, 1996, 17: 241-244.
31. Yamamoto M, Takasaki K, Nakano M, et al. Minute nodular intrahepatic cholangiocareinoma. Cancer, 1998,82:2145-2149.
32. Chen RF, Zou SQ, Zhao XP. The expression of hepatitis C virus gene in hilar cholangiocarcinoma and implication. Chin J Exp Surg, 2000,17:223-224.
33. Yin FZ, Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J, 1998,111 : 1068-1070.
34. Liu FH, Tian GS, Fu XX. The diagnostic value of anti-HCV test in HCV infeetion. Chin J Intern Med, 1994,33:229-230.
35. Panigrahi AK, Nanda SK, Dixit RK, et al. Diagnosis of hepatitis C virusassociatod chronic liver disease in India: Comparison of HCV antibody assay with a polymerase ehain reaction for the 5' noncoding region. J Med Virol, 1994,44: 176-179.
36. Kao J H, Lai M Y, Hwang Y T, et al. Chronic hepatitis C without antihepatitis C antibodies by secand-generation assay: A clinicopathologie study and demonstration of the usefulness of a third-gene:ralion assay. Dig Dis Sci, 1996,41 : 161-165.
37. Hosoda K, Yokosuka O, Onrata M, et al. Detection and partial sequeneing of hepatitis C virus ribonueleic acid in the liver. Gastroenterology, 1991, 101 : 766-771.
38. Sugawara Y, Makuuchi M, Tak~a K. Detectiion of hepatitis B virus DNA in tissues of hepatocellular carcinomas related to hepatitis C virus which are negative for hepatitis B virus surface m~tigen. Scand J Gastroenterol, 1999, 9 : 934-938.
39. Lin XY. In: Luo KX, ed. Hepatitis B-basic biology and clinical science: ttfixed infection of hepatitis virus. Belling: People' s Medical Publishing House, 1997. 279-282
40. Kato N, Lan KH, Ono-Nita SK, et al. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol, 1997, 71: 8856-8859.
41. Yuan M, Huang ZQ. Cholangiocarcinoma as related to intrahepatic stones. Chin J pathol, 1982,11:95-97.
42. Belamarie J. Intrahepatic bile duct carcinoma mad C. Sinensis infection in Hong Kong. Cancer, 1973,31:468-473.
43. Vyberg M.The hepatitis-assoeiated bile duct lesion. Liver, 1993, 13:289-301.
44. Roberts SK, Ludwig J, Larusso NF. The pathobiology of bi|iary epithelia. Gastroenterology, 1997,112 : 269-279.
45. Harada K, Kono N, Tsuneyama K, et al. Cell-kinetic study of proliferating bile duetules in various hepatobiliary diseases. Liver, 1998,18:227-284.